JPRN-UMIN000045798招募中4 期
A RANDOMIZED TRIAL OF CLARITHROMYCIN 800 mg VERSUS 400 mg AS PART OF FIRST-LINE TRIPLE THERAPY - A RANDOMIZED TRIAL OF CLARITHROMYCIN 800 mg VERSUS 400 mg AS PART OF FIRST-LINE TRIPLE THERAPY
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 516
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who have histories of eradication therapy for Helicobacter pylori. 2. Patients who received any one of lansoprazole, esomeprazole, omeprazole, and vonoprazan within 2 weeks. 3. Patients who suggested or received a diagnosis of other infectious diseases. 4. Patients being treated for acute gastritis, advanced gastric cancer, and gastric MALT lymphoma. 5. Patients after gastrectomy. 6. Patients who have coexisting severe heart disease, liver disease, respiratory disease, metabolic disease, neuromuscular disease, and severe chronic renal failure (estimated glomerular filtration rate [eGFR] <30 mL/min/1.73 m2). 7. Patients who have a past history of allergy for vonoprazan, esomeprazole, amoxicillin, and clarithromycin. 8. Pregnancy or lactating women. 9. Patients requiring hospitalization..
研究者
相似试验
进行中（未招募）
1 期
ADMINISTRATION OF CLARITHROMYCIN IN COMMUNITY-ACQUIRED PNEUMONIAAttenuation of the high inflammatory burden in Community-Aquired Pneumonia (CAP)MedDRA version: 20.0Level: PTClassification code 10035664Term: PneumoniaSystem Organ Class: 10021881 - Infections and infestationsEUCTR2020-004452-15-GRHellenic Institute for the Study of Sepsis278
已完成
不适用
Calrithromycin versus first-line antibiotics for acute chronic obstructive pulmonary disease (COPD)Acute chronic obstructive pulmonary disease (COPD)RespiratoryOther chronic obstructive pulmonary diseaseISRCTN03714514niversity of Alberta (Canada) - Faculty of Medicine and Dentistry270
已完成
Unknown
Therapeutic Effects of Clarithromycin and Molnupiravir in Management of COVID-19 PatientsJPRN-UMIN000048841Daido Central Hospital119
已完成
不适用
Study assessing combined therapy with clarithromycin and amoxicillin in childhood acute otitis mediaPediatric patients with childhood acute otitis media determined to be of moderate severity in accordance with the Clinical Practice Guideline for Diagnosis and Management of Acute Otitis Media in Children (2013, hereinafter referred to as the Guideline).JPRN-UMIN000015564Wakayama Medical University otolaryngology, head and neck surgery210
已完成
不适用
Randomized trial of PPI-amoxicillin-clarithromycin and PPI-amoxicillin-metronidazole as first-line Helicobacter pylori eradication therapyJPRN-UMIN000010229The National Hospital Organization120